By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on SpaceX's post-IPO performance, with key risks including overvaluation, reliance on future profits, and potential regulatory headwinds.
Risk: Overvaluation and reliance on future profits
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
By Suzanne McGee, Caroline Valetkevitch and Shashwat Chauhan
NEW YORK, June 15 (Reuters) - The SpaceX IPO went off with a bang. Now investors turn their attention to a jam-packed calendar ahead for Elon Musk's rocket, internet and AI firm that may bring volatility.
Just in the next two months, the sixth-largest U.S. listed company by market value will have a handful of events – ranging from the listing of options to the expiration of investor holding periods to index inclusion – that could help dictate trading in its shares and the broader market.
Friday's launch of the largest-ever IPO was well managed from start to finish, investors said, drawing strong orders from retail and institutions alike and benefiting from Musk's reputation for the Midas touch. But debate continues over what the right price for the stock is and to what extent SpaceX's savvy marketing matches with its fundamentals.
"You have to look at it this way: are people actually investing in SpaceX or trading SpaceX? I am of the belief, and this is also other money managers that I'm talking to, that it's the latter," said Todd Schoenberger, chief investment officer at Crosscheck Management in Washington, D.C.
Here are some events that could help shape that argument over coming weeks:
OPTIONS TRADING
Options on SpaceX are set to begin trading as soon as Tuesday, with early activity expected to be heavy, volatile and likely expensive.
Options, which give holders the right but not the obligation to buy or sell shares at a predetermined price within a certain period, offer investors a low-cost way to play a company's stock. If SpaceX behaves like Musk's Tesla, it would be almost twice as volatile as the average stock, likely driving heavy options activity.
STOCK SALE RESTRICTIONS END
SpaceX plans to allow a large portion of its shares to become eligible for resale before the usual six-month restriction period post-IPO, under a staged system linked to the company's performance, a company filing showed.
The approach, designed to avoid a large wave of shares hitting the market at once, helps make post-IPO trading more orderly - but at the cost of potential volatility spread across the six-month period rather than a single day. Some brokers are also imposing holding periods for shares acquired on Friday.
"We got shares of SpaceX for some of our clients (on Friday), and there's a 31-day minimum holding period," said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. "So I think once some of those minimum holding periods end, you could see some selling pressure."
Four leading AI models discuss this article
"The immediate post-IPO period will be dominated by retail-driven gamma squeezes and forced selling from institutional lock-up expirations, creating a disconnect between price and operational reality."
The market is treating SpaceX as a 'Musk-premium' vehicle rather than a capital-intensive aerospace firm. With options trading commencing Tuesday, expect massive gamma exposure that will likely decouple the stock from its underlying fundamentals—Starlink’s cash flow or launch cadence—for at least a quarter. The article correctly flags the staged lock-up expiration, but misses the deeper risk: SpaceX’s valuation is likely priced for perfection, assuming a monopoly in orbital delivery and high-margin satellite broadband. If Starlink’s subscriber growth hits a plateau or if regulatory scrutiny intensifies, the lack of institutional 'anchor' investors—who are currently waiting for the lock-up dust to settle—will leave retail holding a volatile bag.
If SpaceX’s launch cadence continues to scale exponentially, the company could achieve a 'platform' valuation similar to early-stage AWS, making current price-to-sales ratios look like a bargain in hindsight.
"The IPO's smooth execution and Musk's brand halo have created a valuation floor disconnected from near-term earnings visibility, leaving the stock vulnerable to disappointment once mechanical buying (index inclusion, retail FOMO) exhausts itself."
The article frames SpaceX's IPO as a success, but conflates IPO execution with investment merit. The real risk isn't the near-term catalysts (options, lockup expiry, index inclusion)—those are mechanical and priced in. The risk is fundamental: SpaceX trades at a valuation that assumes flawless execution across Starship commercialization, Starlink profitability, and AI integration, with minimal margin for error. The staged lockup system masks rather than solves selling pressure. Most concerning: the article quotes a money manager saying this is 'trading, not investing,' which is a warning flag about speculative froth, not a bullish signal. Tesla's volatility comparison is apt but cuts both ways.
SpaceX's actual cash generation from Starlink and government contracts is real and growing; the IPO could unlock capital for Starship that materially accelerates timelines, justifying premium valuations that appear speculative today.
"Options trading and staggered share releases will likely transmit volatility from SpaceX into broader tech indices over the next two months."
The article frames the SpaceX IPO as orderly with volatility mainly from options launch and staged lockups over six months. Yet it glosses over how Musk-linked names like Tesla have repeatedly shown that retail-driven pops can reverse sharply once early buyers face any negative catalyst, such as delayed Starlink revenue or regulatory setbacks. Heavy, expensive options activity starting Tuesday will likely embed elevated implied volatility that punishes holders if the stock fails to sustain momentum. Brokers' 31-day holds add another layer of staggered supply that could compound selling pressure rather than contain it.
Staged lockups and strong institutional demand could prevent the classic post-IPO dump, allowing fundamentals to catch up before meaningful supply hits.
"Near-term upside is uncertain and the stock will trade more on IPO mechanics (options, lockups, index effects) than on earnings visibility, creating meaningful downside risk if demand fades."
While the IPO calendar may fuel volatility, the strongest counterpoint to the rosy read is that SpaceX’s public-market story hinges on speculation about future profits, not current earnings. The article highlights options, staged selling, and index-eligibility as drivers, but those mechanics can amplify downside if demand fades or if the company misses guidance. The lack of visible earnings and cash-flow trajectory means valuation depends on long-run monetization bets (Starlink, launches, AI ventures) that could disappoint. Also a relatively small float and potential waves of insider selling over six months could create sporadic volatility--not a clean 'glow-up' after the IPO. Near-term upside is high risk.
However, if SpaceX accelerates Starlink monetization and secures bigger launch pipelines, the stock could re-rate on real revenue visibility, not just investor mania. In that case, the near-term noise from lockups and options would be less relevant than the earnings trajectory.
"SpaceX's valuation pivot from high-margin commercial broadband to cost-plus government contracts represents an overlooked fundamental risk to its growth profile."
Gemini and Claude focus on valuation, but you all miss the geopolitical 'moat' risk. SpaceX isn't just a tech firm; it is a critical defense asset. If the U.S. government mandates launch exclusivity or prioritizes national security payloads over commercial Starlink expansion, the revenue mix shifts from high-margin consumer broadband to lower-margin, cost-plus government contracts. This regulatory capture is a double-edged sword that could compress margins while providing a floor for the stock price during market downturns.
"Government capture protects margins but kills growth—and the IPO is priced for growth, not stability."
Gemini's geopolitical moat argument is real but inverted. Government capture doesn't compress margins—it *guarantees* them. Cost-plus defense contracts are lower-margin than Starlink, yes, but they're also non-cyclical and non-competitive. The actual risk: if national security priorities crowd out commercial launches, SpaceX's growth narrative collapses even if margins hold. Investors bought the growth story, not a defense contractor. That pivot would crater the stock regardless of valuation multiples.
"Defense mandates could stabilize revenue amid lockups but accelerate multiple compression if they delay Starlink growth."
Claude's point that government capture preserves margins but kills the growth story ignores how defense mandates could actually anchor institutional buying during the staged lockups, muting the retail reversal risks Grok noted. The real flaw is assuming investors treat this purely as a Starlink growth bet; a forced pivot to cost-plus contracts might instead compress multiples faster than any options gamma unwind if commercial timelines slip.
"The SpaceX moat from defense demand might cap upside and compress multiples faster than any options unwind if Starlink underperforms or policy cycles swing orders."
Responding to Gemini: The geopolitical moat argument assumes defense demand stabilizes profits. If Starlink monetization slows and launches slip, revenue hurtles toward the government bucket—yet budget cycles, export controls, or policy shifts can rapidly prune those orders or reweight them away from SpaceX. The moat might limit downside, but it could crater growth multiples faster than options gamma unwinds. That makes the stock more sensitive to policy timing than to Starlink revenue visibility.
The panel consensus is bearish on SpaceX's post-IPO performance, with key risks including overvaluation, reliance on future profits, and potential regulatory headwinds.
Overvaluation and reliance on future profits